Stockreport

Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners

INTERPACE BIOSCIENCES INC  (IDXG) 
Last interpace biosciences inc earnings: 11/13 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: interpacediagnostics.com/investors
PDF Reverse Stock Split Planned Concurrent with Closing Investment expected to support achieving cash flow break-even and accelerate Interpace’s growth plans and acquis [Read more]